Explore the Potential with AI-Driven Innovation
This comprehensive focused library is produced on demand with state-of-the-art virtual screening and parameter assessment technology driven by Receptor.AI drug discovery platform. This approach outperforms traditional methods and provides higher-quality compounds with superior activity, selectivity and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
We utilise our cutting-edge, exclusive workflow to develop focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes in-depth molecular simulations of both the catalytic and allosteric binding pockets, with ensemble virtual screening focusing on their conformational flexibility. For modulators, the process includes considering the structural shifts due to reaction intermediates to boost activity and selectivity.
Key features that set our library apart include:
partner
Reaxense
upacc
Q9NPH0
UPID:
PPA6_HUMAN
Alternative names:
Acid phosphatase 6, lysophosphatidic; Acid phosphatase-like protein 1; PACPL1
Alternative UPACC:
Q9NPH0; Q59G61; Q5T490; Q6IAQ3; Q7LG81; Q9UIG6; X5D289
Background:
Lysophosphatidic acid phosphatase type 6, known as Acid phosphatase 6, lysophosphatidic or PACPL1, plays a crucial role in lipid metabolism. It specifically hydrolyzes lysophosphatidic acid (LPA) with medium length fatty acid chains into monoacylglycerol, showing highest activity with myristate (C14:0), oleate (C18:1), and palmitate (C16:0).
Therapeutic significance:
Understanding the role of Lysophosphatidic acid phosphatase type 6 could open doors to potential therapeutic strategies. Its involvement in lipid metabolism suggests its potential impact on diseases related to lipid dysregulation.